| Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program H Bussmann, CW Wester, N Ndwapi, N Grundmann, T Gaolathe, ... Aids 22 (17), 2303-2311, 2008 | 195 | 2008 |
| Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana CW Wester, S Kim, H Bussmann, A Avalos, N Ndwapi, TF Peter, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (3), 336-343, 2005 | 159 | 2005 |
| Overestimates of survival after HAART: implications for global scale-up efforts GP Bisson, T Gaolathe, R Gross, C Rollins, S Bellamy, M Mogorosi, ... PloS one 3 (3), e1725, 2008 | 146 | 2008 |
| High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens F Doualla-Bell, A Avalos, B Brenner, T Gaolathe, M Mine, S Gaseitsiwe, ... Antimicrobial agents and chemotherapy 50 (12), 4182-4185, 2006 | 138 | 2006 |
| Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy GP Bisson, R Gross, JB Strom, C Rollins, S Bellamy, R Weinstein, ... Aids 20 (12), 1613-1619, 2006 | 99 | 2006 |
| Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial CW Wester, OA Okezie, AM Thomas, H Bussmann, S Moyo, T Muzenda, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 46 (3), 318-322, 2007 | 88 | 2007 |
| Safety and efficacy of nevirapine-and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana LK Shipton, CW Wester, S Stock, N Ndwapi, T Gaolathe, I Thior, A Avalos, ... The International journal of tuberculosis and lung disease 13 (3), 360-366, 2009 | 87 | 2009 |
| Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical … H Bussmann, CW Wester, A Thomas, V Novitsky, R Okezie, T Muzenda, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (1), 37-46, 2009 | 64 | 2009 |
| Serological evidence of HIV-associated infection among HIV-1—infected adults in Botswana CW Wester, H Bussmann, S Moyo, A Avalos, T Gaolathe, N Ndwapi, ... Clinical infectious diseases 43 (12), 1612-1615, 2006 | 50 | 2006 |
| Establishment of a public antiretroviral treatment clinic for adults in urban Botswana: lessons learned CW Wester, H Bussmann, A Avalos, N Ndwapi, T Gaolathe, P Cardiello, ... Clinical Infectious Diseases 40 (7), 1041-1044, 2005 | 45 | 2005 |
| Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen F Doualla-Bell, A Avalos, T Gaolathe, M Mine, S Gaseitsiwe, N Ndwapi, ... Antimicrobial agents and chemotherapy 50 (6), 2210-2213, 2006 | 39 | 2006 |
| Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector GP Bisson, I Frank, R Gross, VL Re III, JB Strom, X Wang, M Mogorosi, ... Aids 20 (9), 1333-1336, 2006 | 35 | 2006 |
| Immunohaematological reference values for HIV-negative healthy adults in Botswana M Mine, K Makhaola, C Kamhukamwe, I Mtoni, S Moyo, V Novitsky, ... African journal of laboratory medicine 1 (1), 1-7, 2012 | 30 | 2012 |
| Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a … M Mine, K Bedi, T Maruta, D Madziva, M Tau, T Zana, T Gaolathe, S Moyo, ... Journal of virological methods 159 (1), 93-97, 2009 | 26 | 2009 |
| Mutations and polymorphisms associated with antiretroviral drugs in HIV-1C-infected African patients F Doualla-Bell, S Gaseitsiwe, T Ndung'u, M Modukanele, T Peter, ... Antiviral Chemistry and Chemotherapy 15 (4), 189-200, 2004 | 26 | 2004 |
| Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana T Agizew, R Boyd, N Ndwapi, A Auld, J Basotli, S Nyirenda, Z Tedla, ... PloS one 12 (8), e0183237, 2017 | 25 | 2017 |
| Strengthening healthcare capacity through a responsive, country-specific, training standard: the KITSO AIDS training program’s sup-port of Botswana’s National Antiretroviral … C Bussmann, P Rotz, N Ndwapi, D Baxter, H Bussmann, CW Wester, ... The open AIDS journal 2, 10, 2008 | 25 | 2008 |
| Hybrid data capture for monitoring patients on highly active antiretroviral therapy (HAART) in urban Botswana H Bussmann, CW Wester, N Ndwapi, C Vanderwarker, T Gaolathe, ... Bulletin of the World Health Organization 84 (2), 127-131, 2006 | 19 | 2006 |
| Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana’s Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early … AF Auld, T Agizew, S Pals, A Finlay, N Ndwapi, R Boyd, H Alexander, ... BMC Infectious Diseases 16, 1-14, 2016 | 17 | 2016 |
| Botswana's HIV response: Policies, context, and future directions D Ramogola‐Masire, O Poku, L Mazhani, N Ndwapi, S Misra, ... Journal of community psychology 48 (3), 1066-1070, 2020 | 13 | 2020 |
